Tampa, FL, United States of America

Rajesh R Nair

This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignees: Transgenex Nanobiotech Inc., University of South Florida. Active years: 2019-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rajesh R Nair. Retrieved from https://idiyas.com/inventor/rajesh-r-nair

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 33.3

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Rajesh R Nair

Introduction

Rajesh R Nair is a prominent inventor based in Tampa, Florida. He has made significant contributions to the field of cancer research through his innovative patents. With a total of three patents to his name, Nair's work focuses on advancing the understanding and treatment of cancer.

Latest Patents

One of Nair's latest patents is a system and method of measuring cell viability and growth. This novel SH-SAW biosensor is capable of non-invasive and touch-free detection of cancer cell viability and growth or proliferation in both two-dimensional (2D) and three-dimensional (3D) cell cultures. It also plays a crucial role in stem cell regeneration as it pertains to cancer cell biology and anti-cancer drug development. The biosensor includes two pairs of resonators with interdigital transducers reflecting fingers to quantify mass loading by the cells in suspension and within a tumoroid culture platform. This technology can be integrated into a perfused 3PNS-tumoroid system, allowing for real-time non-invasive monitoring of cell proliferation, viability, and multiplexed detection of key physiological and clinical biomarkers.

Another significant patent involves methods and compositions for treating drug resistance in cancer. This patent discloses compositions and methods aimed at reducing, inhibiting, or preventing resistance of cancer to tyrosine kinase inhibitors. The methods may include administering an anti-resistance agent, such as a CYP51A1 inhibitor or an agonist of miRNA-764, to a subject. Additionally, a tyrosine kinase inhibitor may also be administered alongside the anti-resistance agent.

Career Highlights

Rajesh R Nair has worked with notable organizations, including the University of South Florida and Transgenex Nanobiotech Inc. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Nair has collaborated with esteemed colleagues such as Shyam S Mohapatra and Subhra Mohapatra. Their joint efforts have further advanced the research and development of innovative solutions in cancer treatment.

Conclusion

Rajesh R Nair's contributions to cancer research through his innovative patents highlight his dedication to improving treatment options for patients. His work continues to pave the way for advancements in the field, showcasing the importance of innovation in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…